Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 755 All time
- Disclosed funding
- $25.4B 617 disclosed amounts
- Median round
- $15.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| R RyloCompany profile Provides AI-powered communication tools for the Deaf and hard-of-hearing community Provides AI-powered communication tools for the Deaf and hard-of-hearing community | $85M | Growth | Healthtech | United States | Investors | |
| EB Element BiosciencesCompany profile Develops genomic and multiomic sequencing platforms for research, translational science, and diagnostics Develops genomic and multiomic sequencing platforms for research, translational science, and diagnostics | $175M | Series ESeries C+ | Healthtech, Biotech | United States | Investors | |
| TP Membership club dedicated to human flourishing and wellness | $5M | Undisclosed | Healthtech, Consumer | United States | Investors Andrew BoggsAneil Mallavarapu +25Ankush GeraBen ArnbergElaine GlassEmmet PeppersJacqui BishopJoshua DouglasJP NewmanKwiri YangLinea AveyManish ChandraMatt EggersMatt MovalsonMatt MullenwegMelissa TauntonMichael FishmanMichael HeinrichMichael SolomonMimi AyeRavi BhojwaniScott FaberShaunda BrownSpencer KayeTim FerrissVishal GurbuxaniZander Rafael | |
| S Offers accelerated, affordable training for healthcare careers | $55M | Series CSeries C+ | Healthtech | United States | Investors | |
| CT City TherapeuticsCompany profile City Therapeutics develops RNA-interference therapeutics and an engineering platform across disease areas. City Therapeutics develops RNA-interference therapeutics and an engineering platform across disease areas. | $99.5M | Series B | Healthtech, Biotech | United States | Investors | |
| OP Develops RNAi therapeutics for various diseases | ₩110B | StrategicUndisclosed | Healthtech, Biotech | South Korea | Investors | |
| C CereVascCompany profile Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases | $85M | Series CSeries C+ | Healthtech | United States | Investors | |
| S Provides healthcare management platform for outpatient providers | £30M | Series CSeries C+ | Healthtech | United Kingdom | Investors | |
| AB ARTAN BioCompany profile Develops mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions Develops mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions | $200K | Seed | Healthtech, Biotech | United States | Investors | |
| FH Flok HealthCompany profile AI-operated digital physiotherapy clinic delivering autonomous musculoskeletal care pathways via mobile app AI-operated digital physiotherapy clinic delivering autonomous musculoskeletal care pathways via mobile app | $12.5M | Series A | Healthtech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.